You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Ustekinumab for moderately to severely active Crohn’s disease after previous treatment

  • Technology appraisal guidance
  • Reference number: TA456
  • Published:  12 July 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Final appraisal determination
  2. Invitation to participate

History

Documents created during the development process.

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 440 KB)

    Published:
    27 April 2017
  • Public committee slides (PDF 460 KB)

    Published:
    27 April 2017
  • Public committee slides (PDF 458 KB)

    Published:
    27 April 2017
  • Final appraisal determination document Equality Impact Assessment (PDF 223 KB)

    Published:
    27 April 2017
  • Final appraisal determination document 2nd Final appraisal determination (PDF 444 KB)

    Published:
    16 June 2017

Invitation to participate

  • Final scope (PDF 171 KB)

    Published:
    06 October 2016
  • Final matrix (PDF 153 KB)

    Published:
    06 October 2016
  • Draft scope and provisional matrix comments table (post-referral) (PDF 214 KB)

    Published:
    06 October 2016
  • Equality impact assessment (Scoping) (PDF 121 KB)

    Published:
    06 October 2016
Back to top